UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1997
---------------------------------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
------------------ ------------------
Commission file number 01-14358
--------
Harborside Healthcare Corporation
------------------------------------------------------------------------------
Delaware 04-3307188
------------------------------------------------------------------------------
(State or other jurisdiction of (IRS employer identification no.)
incorporation or organization)
470 Atlantic Avenue, Boston, Massachusetts 02210
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(617) 556-1515
- -------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
--- ---
Number of shares of common stock, par value $0.01 per share outstanding as of
August 13, 1997: 8,001,999.
<PAGE>
2
EXPLANATORY NOTE
The purpose of this Amendment No.1 to the Company's Quarterly Report on Form
10-Q is to restate the Company's response to Item 4 of Part II of the Report in
its entirety.
Part II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
The Company's Annual Meeting of Stockholders was held on May 14,
1997. At the meeting, Stephen L. Guillard and David F. Benson were
elected to the board of directors for three-year terms with
7,807,360 votes cast in favor and 9,200 votes cast against each of
the two directors. Robert T. Barnum, Robert M. Bretholtz, Sally W.
Crawford, Laurence Gerber and Douglas Krupp continue to serve their
terms of office following the meeting.
<PAGE>
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Harborside Healthcare Corporation
By: /s/ Stephen L. Guillard
--------------------------------
Stephen L. Guillard
Chairman, President, and Chief Executive Officer
By: /s/ William H. Stephan
--------------------------------
William H. Stephan
Senior Vice President and Chief Financial Officer
DATE: August 18, 1997
